Literature DB >> 23769411

When do we discontinue anti-dementia drugs? Views expressed by clinicians in a national survey within the United Kingdom.

Rinki Ray, Richard Prettyman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23769411     DOI： 10.1017/S104161021300094X

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN： 1041-6102            Impact factor:   3.878


× No keyword cloud information.
  3 in total

1.  Risk for Health Events After Deprescribing Acetylcholinesterase Inhibitors in Nursing Home Residents With Severe Dementia.

Authors:  Joshua D Niznik; Xinhua Zhao; Meiqi He; Sherrie L Aspinall; Joseph T Hanlon; Laura C Hanson; David Nace; Joshua M Thorpe; Carolyn T Thorpe
Journal:  J Am Geriatr Soc       Date:  2019-11-26       Impact factor: 5.562

Review 2.  The cholinergic system in the pathophysiology and treatment of Alzheimer's disease.

Authors:  Harald Hampel; M-Marsel Mesulam; A Claudio Cuello; Martin R Farlow; Ezio Giacobini; George T Grossberg; Ara S Khachaturian; Andrea Vergallo; Enrica Cavedo; Peter J Snyder; Zaven S Khachaturian
Journal:  Brain       Date:  2018-07-01       Impact factor: 13.501

3.  A 2-year prospective cohort study of antidementia drug non-persistency in mild-to-moderate Alzheimer's disease in Europe : predictors of discontinuation and switch in the ICTUS study.

Authors:  Virginie Gardette; Maryse Lapeyre-Mestre; Antoine Piau; Adeline Gallini; Christelle Cantet; Jean-Louis Montastruc; Bruno Vellas; Sandrine Andrieu
Journal:  CNS Drugs       Date:  2014-02       Impact factor: 5.749
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.